Ticker: TIL

Instil Bio, Inc. (NASDAQ: TIL) - concise operational and income-statement snapshot Quick financial snapshot (amounts per 10‑Q are in thousands): * Cash and cash equivalents (6/30/2025): $7,688; cash, cash equivalents and restricted cash-end of period: $7,838 (vs $10,635 at 12/31/2024). * Marketab...

Instil Bio, Inc. (NASDAQ: TIL) Overview Instil Bio is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for cancer treatment. The company's current portfolio is highlighted by its lead product candidate, AXN-2510/IMM2510, a bispecific antibody targeting programm...